Pendulum Glucose Control News Today

SAN FRANCISCO, June 27, 2023--Pendulum Therapeutics, the biotech company pioneering the next frontier of metabolic health through its microbiome-targeted products, announced today a strategic partnership with New Zealand dairy nutrition company Fonterra. Fonterra will invest $10 million into the growth-stage company to co-develop and commercialize next-generation microbiome products.

San Francisco, California (PRWEB) January 27, 2022 -- Pendulum Therapeutics, a leader in harnessing evidence-based microbiome science and DNA sequencing to

/PRNewswire/ -- Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading healthcare professional education on the...

/PRNewswire/ -- Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading healthcare professional education on the...

Pendulum Therapeutics Raises $54 million Gut health biotech company Pendulum Therapeutics recently announced a $54 million investment led by Meritech Capital with participation from existing investors including Sequoia Capital, True Ventures and Khosla Ventures. The Series C round nearly doubled the entirety of Pendulum’s previous raises, bringing the total venture capital raised to $111 million. As lead investor, Meritech General Partner Craig Sherman will take ...

Pendulum Therapeutics Raises $54 Million to Meet Surging Customer Demand Strong Loyalty Among Subscribers: After Five Months, 74% of Key Customer Segment Remain Active Users Company Created New Product Category, Filling Market Gap Between Supplements and Prescription Drugs News provided by Share this article SAN FRANCISCO, April 7, 2021 /PRNewswire/ --  Pendulum Therapeutics – a biotech company improving health through products targeting the microbiome – today announced a $54 million inves...

To embed, copy and paste the code into your website or blog: Welcome to our monthly roundup of regulatory and litigation highlights impacting the dietary supplement and personal care products industries.  Sit back, relax, and enjoy the read.  February was a short month, with a lot going on. NAD Health claim substantiation was front and center before NAD in a monitoring case involving Pendulum Therapeutics and a “medical probiotic” product featuring claims such as “The only medical probi...

NAD supports claims being made by ‘medical probiotic’ manufacturer ©Getty Images - Image_Jungle Probiotics manufacturer Pendulum Therapeutics Inc. got some welcome news today when the National Advertising Division announced that it has found that the claims the company makes for dietary control of Type 2 diabetes are supported by scientific evidence. The NAD ruling said that the scientific study that Pendulum Therapeutics submitted in response to the action supp...